← SynDRA
MENATETRENONE
SynDRA canonical compound SYN0009036 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | bone resorption inhibitor |
|---|
| Indication | osteoporosis |
|---|
| Disease area | orthopedics |
|---|
All known targets
Mechanisms of action (all sources)
- bone resorption inhibitor
- Trypano CYSP INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTGS1
- DRD3
- ADORA3
- PDE3A
- PDE4A
- ESR1
- CYP3A4
- MAPT
- NR1I2
- OPRM1
- PGR
- POLI
- ACHE
- MAOA
- PTH1R
- RAPGEF3
- SLC6A2
- SLC6A3
- SLC6A4
- SMAD3
- TBXA2R
- TDP1
- MAPK1
- KCNH2
- KDR
- HTR2B
- ADRA1A
- ADRA2A
- APEX1
- AR
- ATAD5
- BAZ2B
- CHRM1
- CHRM2
- DRD1
- EHMT2
- F2
- GGCX
- HDAC6
- HRH3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- CP2C9
- CP3A4
- CP3A7
- CYP2C9
- G3P
Drug classes
- Coagulants
- Hematologic Agents
- Hemostatics
- Antifibrinolytic Agents
- Micronutrients
- Vitamins
ATC classes
- M05B · DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Cross-references
Synonyms
- Menaquinone 4
- Vitamin MK 4
- vitamin k2
- Menatetrenona
- Menaquinone-4
- Kaytwo
- Kaytwo n
- Menatetranone
- Vitamin k2(20)
- VITAMIN K2
- menaquinone-2
- MK-2
- menaquinone(2)
- AC1NQWYQ
- Prestwick3_001100
- BSPBio_001180
- SCHEMBL416517
- 2-(3,7-dimethylocta-2,6-dienyl)-3-methylnaphthalene-1,4-dione
- CHEMBL263382
- BPBio1_001298
- GTPL2771
- PTWSIIUEOFZCHW-NTCAYCPXSA-N
- HMS2098K22
- 2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone
- 1,4-Naphthoquinone, 2-(3,7-dimethyl-2,6-octadienyl)-3-methyl-
- ZINC1532757
- AKOS015899893
- CJ-24250
- AB00514047
- C00828
- I14-11159
- 2-Methyl-3-(3,7-dimethyl-2,6-octadienyl)-1,4-naphthoquinone
- Menaquinone K4
- vitamin K2(20)
- vitamin MK-4
- Menatetrenonum
- MENATETRANONE
- 2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone
Look up MENATETRENONE in the interactive SynDRA portal →